Items where authors include "Pieber, T.R."

Article

Heller, S. orcid.org/0000-0002-2425-9565, Battelino, T. orcid.org/0000-0002-0273-4732, Bailey, T.S. orcid.org/0000-0003-4178-3462 et al. (8 more authors) (2023) Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes. Diabetes, Obesity and Metabolism. ISSN 1462-8902

Pieber, T.R., Bajaj, H.S., Heller, S.R. orcid.org/0000-0002-2425-9565 et al. (7 more authors) (2022) Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes : a post hoc analysis of the CONCLUDE trial. Diabetes, Obesity and Metabolism, 24 (2). pp. 332-336. ISSN 1462-8902

Fabricius, T.W., Verhulst, C.E.M., Kristensen, P.L. et al. (8 more authors) (2021) Hyperinsulinaemic–hypoglycaemic glucose clamps in human research: a systematic review of the literature. Diabetologia, 64 (4). pp. 727-736. ISSN 0012-186X

Heller, S. orcid.org/0000-0002-2425-9565, Lingvay, I., Marso, S.P. et al. (10 more authors) (2020) Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE. Diabetes, Obesity and Metabolism, 22 (12). pp. 2241-2247. ISSN 1462-8902

Galan, B.E., McCrimmon, R.J., Ibberson, M. et al. (9 more authors) (2020) Reducing the burden of hypoglycaemia in people with diabetes through increased understanding : design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) project. Diabetic Medicine, 37 (6). pp. 1066-1073. ISSN 0742-3071

Philis-Tsimikas, A., Klonoff, D.C., Khunti, K. et al. (7 more authors) (2020) Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes : the randomised, head-to-head CONCLUDE trial. Diabetologia, 63 (4). pp. 698-710. ISSN 0012-186X

Pollock, R.F., Heller, S. orcid.org/0000-0002-2425-9565, Pieber, T.R. et al. (6 more authors) (2019) Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9). Diabetes, Obesity and Metabolism, 21 (7). pp. 1706-1714. ISSN 1462-8902

Heller, S. orcid.org/0000-0002-2425-9565, Bowering, K., Raskin, P. et al. (4 more authors) (2018) The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis. Diabetic Medicine , 35 (9). pp. 1273-1278. ISSN 0742-3071

Pieber, T.R., Marso, S.P., McGuire, D.K. et al. (14 more authors) (2018) DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia, 61 (1). pp. 58-65. ISSN 0012-186X

Mader, J.K., Jensen, L., Ingwersen, S.H. et al. (3 more authors) (2016) Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus. Clinical Pharmacokinetics. ISSN 0312-5963

Thabit, H., Leelarathna, L., Wilinska, M.E. et al. (16 more authors) (2015) Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions. Diabetes Technology and Therapeutics, 17 (11). pp. 801-807. ISSN 1520-9156

Koehler, G., Heller, S. orcid.org/0000-0002-2425-9565, Korsatko, S. et al. (4 more authors) (2014) Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study. Diabetologia, 57 (1). pp. 40-49. ISSN 0012-186X